X
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.prnewswire.com/news-releases/m8-pharmaceuticals-an-acino-company-signs-an-exclusive-agreement-with-serb-pharmaceuticals-to-bring-voraxaze-glucarpidase-to-latin-america-302093643.html
https://www.onclive.com/view/nccn-issues-guideline-update-on-the-use-of-high-dose-methotrexate-glucarpidase-in-all-b-cell-lymphoma
https://www.pharmacompass.com/pdf/news/serb-receives-positive-chmp-opinion-for-voraxaze-glucarpidase-as-rescue-therapy-for-high-dose-methotrexate-toxicity-1639817595.pdf
https://www.prnewswire.com/news-releases/initial-study-results-show-feasibility-of-outpatient-methotrexate-administration-with-planned-use-voraxaze-glucarpidase-during-covid-19-pandemic-301171687.html
https://www.prnewswire.com/news-releases/btg-specialty-pharmaceuticals-announces-the-european-medicines-agency-has-accepted-for-review-a-marketing-authorisation-application-for-voraxaze-301113141.html
https://www.prnewswire.com/news-releases/study-underway-to-examine-the-planned-use-of-voraxaze-with-methotrexate-in-cns-lymphoma-301045797.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125327
Market Place
Share 
